<p><strong>By Ashutosh Joshi and Nupur Acharya,</strong></p>.<p>India’s best-performing stock funds have one thing in common: they’ve bet on companies that make the chemical substances used in items ranging from lip balms to crop-boosting fertilisers.</p>.<p>Chemicals producers make up at least 14% of the portfolio for three funds that have delivered the biggest returns this year among those with at least $500 million in total assets, according to Bloomberg-compiled data. Those bets have paid off thanks to rising global appetite for specialty chemicals in industries such as automobiles and cosmetics amid a recovery from the pandemic.</p>.<p>India is emerging as a hub for specialty chemicals, helped by favourable policy measures that include decisions such as imposing anti-dumping duty on some imports and a proposal for production-linked incentives. Producers have also benefited from a ‘China-plus-one’ strategy that has made companies around the world diversify their supply chains from the Asian superpower amid geopolitical concerns.</p>.<p>“We continue to be very optimistic on the long-term prospects of the chemical industry in India,” as it becomes an important player in the global supply chain, said Samir Rachh, who helps manage the nearly $2 billion Nippon India Small Cap Fund, the best performer with a 42% return year-to-date.</p>.<p>The biggest holding in Rachh’s fund is Deepak Nitrite Ltd., a maker of phenol and acetone used in numerous applications including mouthwash and nail-polish remover. He initiated that position in 2017 and increased it in 2019.</p>.<p>Shares of the firm based in India’s western Gujarat state have risen nearly 89% so far this year, taking their surge over the last five years close to 2,000%. Its revenue has more than tripled in the period to 43.6 billion rupees ($595 million) for the fiscal year ended March.</p>.<p>The country’s chemicals companies are ramping up capex investments to produce high-value goods and expand their share of the global market, said Venugopal Manghat, who manages the $894 million L&T Emerging Businesses Fund.</p>.<p>Four of the top five funds in India this year are those that focus on small-cap stocks, an asset class that has handily beaten the benchmark index. The S&P BSE Smallcap index has surged almost 40% in 2021, compared to 10% for the S&P BSE Sensex Index.</p>
<p><strong>By Ashutosh Joshi and Nupur Acharya,</strong></p>.<p>India’s best-performing stock funds have one thing in common: they’ve bet on companies that make the chemical substances used in items ranging from lip balms to crop-boosting fertilisers.</p>.<p>Chemicals producers make up at least 14% of the portfolio for three funds that have delivered the biggest returns this year among those with at least $500 million in total assets, according to Bloomberg-compiled data. Those bets have paid off thanks to rising global appetite for specialty chemicals in industries such as automobiles and cosmetics amid a recovery from the pandemic.</p>.<p>India is emerging as a hub for specialty chemicals, helped by favourable policy measures that include decisions such as imposing anti-dumping duty on some imports and a proposal for production-linked incentives. Producers have also benefited from a ‘China-plus-one’ strategy that has made companies around the world diversify their supply chains from the Asian superpower amid geopolitical concerns.</p>.<p>“We continue to be very optimistic on the long-term prospects of the chemical industry in India,” as it becomes an important player in the global supply chain, said Samir Rachh, who helps manage the nearly $2 billion Nippon India Small Cap Fund, the best performer with a 42% return year-to-date.</p>.<p>The biggest holding in Rachh’s fund is Deepak Nitrite Ltd., a maker of phenol and acetone used in numerous applications including mouthwash and nail-polish remover. He initiated that position in 2017 and increased it in 2019.</p>.<p>Shares of the firm based in India’s western Gujarat state have risen nearly 89% so far this year, taking their surge over the last five years close to 2,000%. Its revenue has more than tripled in the period to 43.6 billion rupees ($595 million) for the fiscal year ended March.</p>.<p>The country’s chemicals companies are ramping up capex investments to produce high-value goods and expand their share of the global market, said Venugopal Manghat, who manages the $894 million L&T Emerging Businesses Fund.</p>.<p>Four of the top five funds in India this year are those that focus on small-cap stocks, an asset class that has handily beaten the benchmark index. The S&P BSE Smallcap index has surged almost 40% in 2021, compared to 10% for the S&P BSE Sensex Index.</p>
